Astria Therapeutics, Inc. Assets, Fair Value Disclosure
Astria Therapeutics, Inc. had Assets, Fair Value Disclosure of $207.86 million as of 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2023-03-22
- 2022-12-31: Assets, Fair Value Disclosure $207.86M.
- 2021-12-31: Assets, Fair Value Disclosure $40.85M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2022-12-31 | $207.86M 10-K · filed 2023-03-22 |
| 2021-12-31 | $40.85M 10-K · filed 2023-03-22 |